FocusCancer

Why geneticists stole cancer research even though cancer is primarily a signaling disease

See allHide authors and affiliations

Sci. Signal.  22 Jan 2019:
Vol. 12, Issue 565, eaaw3483
DOI: 10.1126/scisignal.aaw3483

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Genetic approaches to cancer research have dramatically advanced our understanding of the pathophysiology of this disease, leading to similar genetics-based approaches for precision therapy, which have been less successful. Reconfiguring and adapting the types of technologies that underlie genetic research to dissect tumor cell signaling in clinical samples may offer an alternative road forward.

View Full Text